US Stock MarketDetailed Quotes

PRLD Prelude Therapeutics

Watchlist

1.215
-0.125-9.33%

Trading Dec 30 11:12 ET

66.87MMarket Cap-0.69P/E (TTM)

Prelude Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Prelude Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	3.000M / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q33.000M / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Prelude Therapeutics Earnings Reports

Prelude Therapeutics | 8-K: Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 6 22:32 ET

Prelude Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6 16:32 ET

Prelude Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 07:26 ET

Prelude Therapeutics | 8-K: Prelude Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12 07:15 ET

Analyst Rating

Updated: Dec 30, 2024

Hold

Buy
50.00%
Hold
0.00%
Sell
50.00%

Price Target

No Data

Heat List

Overall